Home

Ratniče nastavi zahtjev median overall survival non hodgkins lymphoma skala Sto godina glavna zemlja

Frontiers | Survival Trends in Patients Under Age 65 Years With Mantle Cell  Lymphoma, 1995–2016: A SEER-Based Analysis | Oncology
Frontiers | Survival Trends in Patients Under Age 65 Years With Mantle Cell Lymphoma, 1995–2016: A SEER-Based Analysis | Oncology

The outcome of peripheral T-cell lymphoma patients failing first-line  therapy: a report from the prospective, International T-Cell Project |  Haematologica
The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project | Haematologica

The Natural History of Initially Untreated Low-Grade Non-Hodgkin's Lymphomas  | NEJM
The Natural History of Initially Untreated Low-Grade Non-Hodgkin's Lymphomas | NEJM

Overall survival of 104 patients with non-Hodgkin lymphoma after ASCT... |  Download Scientific Diagram
Overall survival of 104 patients with non-Hodgkin lymphoma after ASCT... | Download Scientific Diagram

Overall Survival of 3,315 Non-Hodgkin's Lymphoma (NHL) Patients... |  Download Scientific Diagram
Overall Survival of 3,315 Non-Hodgkin's Lymphoma (NHL) Patients... | Download Scientific Diagram

Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy  and autologous SCT and impact of various prognostic factors on overall and  event-free survival. A single institution result of 66 patients | Bone  Marrow
Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients | Bone Marrow

Overall Survival of 3,315 Non-Hodgkin's Lymphoma (NHL) Patients... |  Download Scientific Diagram
Overall Survival of 3,315 Non-Hodgkin's Lymphoma (NHL) Patients... | Download Scientific Diagram

Predictive value of serological factors, maximal standardized uptake value  and ratio of Ki67 in patients diagnosed with non‑Hodgkin's lymphoma
Predictive value of serological factors, maximal standardized uptake value and ratio of Ki67 in patients diagnosed with non‑Hodgkin's lymphoma

Follicular lymphoma in the modern era: survival, treatment outcomes, and  identification of high-risk subgroups | Blood Cancer Journal
Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups | Blood Cancer Journal

Predicting worse survival for newly diagnosed T cell lymphoma based on the  decreased baseline CD16−/CD16 + monocyte ratio | Scientific Reports
Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16−/CD16 + monocyte ratio | Scientific Reports

Non-Hodgkin lymphoma survival statistics | Cancer Research UK
Non-Hodgkin lymphoma survival statistics | Cancer Research UK

The Revised International Prognostic Index (R-IPI) Score Is Predictive Of  Survival In Aggressive Transformed Lymphomas (TL) From Low Grade Non-Hodgkin  Lymphomas In The Chemoimmunotherapy Era - ScienceDirect
The Revised International Prognostic Index (R-IPI) Score Is Predictive Of Survival In Aggressive Transformed Lymphomas (TL) From Low Grade Non-Hodgkin Lymphomas In The Chemoimmunotherapy Era - ScienceDirect

Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A  retrospective multicentric cohort study - eClinicalMedicine
Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study - eClinicalMedicine

High combined individual and neighborhood socioeconomic status correlated  with better survival of patients with lymphoma in post-rituximab era  despite universal health coverage - ScienceDirect
High combined individual and neighborhood socioeconomic status correlated with better survival of patients with lymphoma in post-rituximab era despite universal health coverage - ScienceDirect

Primary Non-Hodgkin's Lymphoma of the Gallbladder: A Population-based  Analysis | Anticancer Research
Primary Non-Hodgkin's Lymphoma of the Gallbladder: A Population-based Analysis | Anticancer Research

Non-Hodgkin lymphoma survival statistics | Cancer Research UK
Non-Hodgkin lymphoma survival statistics | Cancer Research UK

Treatment of Children and Young Adults with Early-Stage Non-Hodgkin's  Lymphoma | NEJM
Treatment of Children and Young Adults with Early-Stage Non-Hodgkin's Lymphoma | NEJM

Age-standardized incidence and mortality rates of Hodgkin's lymphoma... |  Download Scientific Diagram
Age-standardized incidence and mortality rates of Hodgkin's lymphoma... | Download Scientific Diagram

Prolonged survival in the absence of disease-recurrence in advanced-stage  follicular lymphoma following chemo-immunotherapy: 13-year update of the  prospective, multicenter randomized GITMO-IIL trial | Haematologica
Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial | Haematologica

Investigation on treatment strategy, prognostic factors, and risk factors  for early death in elderly Taiwanese patients with diffuse large B-cell  lymphoma | Scientific Reports
Investigation on treatment strategy, prognostic factors, and risk factors for early death in elderly Taiwanese patients with diffuse large B-cell lymphoma | Scientific Reports

Prognostic nomogram incorporating inflammatory cytokines for overall  survival in patients with aggressive non-Hodgkin's lymphoma - eBioMedicine
Prognostic nomogram incorporating inflammatory cytokines for overall survival in patients with aggressive non-Hodgkin's lymphoma - eBioMedicine

Overall survival according to the Follicular Lymphoma International... |  Download Scientific Diagram
Overall survival according to the Follicular Lymphoma International... | Download Scientific Diagram

Patients with classical Hodgkin lymphoma experiencing disease progression  after treatment with brentuximab vedotin have poor outcomes - Annals of  Oncology
Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes - Annals of Oncology

High-Dose Chemotherapy Followed by Autologous Stem Cell Rescue for  Refractory Hodgkin's Disease and Non-Hodgkin's Lymphoma A. P. Rapoport, J.  M. Rowe, and J. F Dipersio In: Zander AR, Barlogie B (eds) Autologus Bone  Marrow ...
High-Dose Chemotherapy Followed by Autologous Stem Cell Rescue for Refractory Hodgkin's Disease and Non-Hodgkin's Lymphoma A. P. Rapoport, J. M. Rowe, and J. F Dipersio In: Zander AR, Barlogie B (eds) Autologus Bone Marrow ...

Overall survival (OS) of patients with follicular lymphoma who had... |  Download Scientific Diagram
Overall survival (OS) of patients with follicular lymphoma who had... | Download Scientific Diagram

Long‐term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin  lymphoma: A pooled analysis of four randomized trials - André - 2020 -  Cancer Medicine - Wiley Online Library
Long‐term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials - André - 2020 - Cancer Medicine - Wiley Online Library

Patterns of change in treatment, response, and outcome in patients with  follicular lymphoma over the last four decades: a single-center experience  | Blood Cancer Journal
Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience | Blood Cancer Journal